A common antidepressant weakens or cancels the beneficial effects of a standard treatment for breast cancer, according to a study released Tuesday. Women who take the mood drug paroxetine — better known by its brand names Paxil and Seroxat — at the same time as the breast cancer medication tamoxifen face an increased risk of death, researchers reported. Source: General Cancer News Articles Provided by Cancer Compass